COMMUNIQUÉS West-GlobeNewswire

Intra-Cellular Therapies to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

09/05/2018 - 14:00

NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today [...]

Krystal Biotech Presents In Vivo KB103 Data at the International Investigative Dermatology Conference that Show Human COL7 Incorporating into Anchoring Fibrils with Proper Structural Orientation

09/05/2018 - 14:00

Lead product candidate, KB103, shown to successfully transfer COL7A1 gene and to correct recessive dystrophic epidermolysis bullosa (RDEB) PITTSBURGH, May 09, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. , (“Krystal [...]

Selecta Biosciences Announces First Quarter 2018 Financial Results and Provides Corporate Update

09/05/2018 - 14:00

3-month Phase 2 data presented at PANLAR 2018 indicate SEL-212 (SVP-Rapamycin + pegsiticase) product profile may provide better and more sustained serum uric acid control, fewer flares, and less frequent dosing compared [...]

CareDx expands NGS Transplant Product Offerings

09/05/2018 - 14:00

License and Commercialization Agreement with Illumina BRISBANE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- CareDx (NASDAQ: CDNA ), today announced that, as reported in its Current Report on Form 8-K filed with the [...]

Wave Life Sciences Reports First Quarter 2018 Financial Results and Provides Business Update

09/05/2018 - 14:00

CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE ), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases [...]

Nephros Reports First Quarter 2018 Financial Results

09/05/2018 - 13:45

Quarterly Product Revenue Up 39% Year-over-Year; Reiterates Full Year 2018 Revenue Guidance of $6 Million SOUTH ORANGE, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage [...]

Amicus Therapeutics to Present at Bank of America Merrill Lynch 2018 Health Care Conference

09/05/2018 - 13:30

CRANBURY, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Bank of America [...]

Progenics Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update

09/05/2018 - 13:30

Pre-Commercial Launch Preparations Underway for AZEDRA ® (iobenguane I 131) ahead of U.S. Food and Drug Administration (FDA) July 30 th Action Date Top-Line Data from Phase 3 Trial for PSMA-Targeted SPECT/CT Imaging [...]

Adaptimmune Reports First Quarter 2018 Financial Results and Business Update

09/05/2018 - 13:30

- Dosing patients in MAGE-A10 lung cancer study at one billion target cell dose - - Updated MRCLS response data will be presented in an oral presentation at ASCO - - Guidance confirmed, funded through to early 2020 - - [...]

Paratek Pharmaceuticals Reports First Quarter 2018 Financial Results

09/05/2018 - 13:30

-- New drug applications for omadacycline accepted for priority review by FDA; PDUFA action date in October 2018 -- -- Company on track for a first quarter 2019 omadacycline U.S. launch -- -- Company strengthens balance [...]

Ovid Therapeutics Announces Two Oral Presentations at the 14th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV)

09/05/2018 - 13:01

New preclinical data provide further evidence of TAK-935/OV935’s novel mechanism of action, as a potential treatment for rare developmental and epileptic encephaolopathies (dEE) First presentation of preclinical data on [...]

ProQR Announces Results for the First Quarter of 2018

09/05/2018 - 13:00

Key updates Eight out of twelve patients have been enrolled in a Phase 1/2 clinical trial of QR-110 in adults and children with LCA 10. Interim data are expected in the second half of 2018, with full data expected [...]

Neos Therapeutics Reports First Quarter 2018 Financial Results

09/05/2018 - 13:00

Company to Host Conference Call at 8:30am ET Today DALLAS and FORT WORTH, Texas, May 09, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing [...]

Idera Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

09/05/2018 - 13:00

EXTON, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic [...]

Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY® ER

09/05/2018 - 13:00

– June 26 th Advisory Committee Meeting for REMOXY ER – – August 7 th PDUFA Target Date for REMOXY ER – AUSTIN, Texas, May 09, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ), a drug development company [...]

Kamada to Announce First Quarter 2018 Financial Results and Host Conference Call on May 15

09/05/2018 - 13:00

REHOVOT, Israel, May 09, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company, today announced that it will release financial results for the quarter ended [...]

Surgery Partners, Inc. Announces First Quarter 2018 Results

09/05/2018 - 13:00

Quarterly Highlights Reflect Significant Strategic Progress; Affirms Full Year Expectations BRENTWOOD, Tenn., May 09, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company [...]

R1 RCM Reports First Quarter 2018 Results

09/05/2018 - 13:00

CHICAGO, May 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]

Protalix BioTherapeutics Reports 2018 First Quarter Results and Provides Corporate Update

09/05/2018 - 13:00

CARMIEL, Israel, May 09, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]